Abstract:Background: Primary cutaneous gamma/delta T-cell lymphoma (PCDG-TCL) is aggressive, frequently presenting as multiple plaques, tumors, and/or subcutaneous nodules.Methods: In this study, we conducted a retrospective study in a tertiary center in Taiwan to characterize this rare tumor.
Results:We identified six patients. Five presented with a solitary lesion, including two with clinical impression of epidermal inclusion cyst or lipoma. Two of four evaluable cases exhibited epidermotropism, with one mimicking Pa… Show more
“…5,6 A few indolent cases have been reported. 1,[7][8][9] The clinical presentation of such indolent PCGDTCL has been poorly described. We provide a retrospective multicentre series of five indolent PCGDTCL cases.…”
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebocontrolled and ustekinumab-controlled phase 3 trials.
“…5,6 A few indolent cases have been reported. 1,[7][8][9] The clinical presentation of such indolent PCGDTCL has been poorly described. We provide a retrospective multicentre series of five indolent PCGDTCL cases.…”
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebocontrolled and ustekinumab-controlled phase 3 trials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.